Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate
Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule Higher antibody levels were observed in the three-dose vaccination schedule versus the two-dose... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 1, 2022 Category: Pharmaceuticals Source Type: clinical trials

Place of Intrathecal CXCL-13 in the Diagnosis of Lyme Neuroborreliosis
Condition:   Lyme Borreliosis Intervention:   Sponsor:   University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2022 Category: Research Source Type: clinical trials